AzTrials
AzTrials

DynapeniaNCT07534150

Blood Flow Restriction Parameters and Lower Limb Function in Older Adults With Dynapenia

A study testing Blood Flow Restriction and Conventional Resistance Training in people with Dynapenia, run by Kaohsiung Medical University at 1 site in Taiwan.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The objective of the first year is to collect limb occlusion pressure (LOP) measurements in older adults with varying levels of muscle health, which will serve as foundational data for subsequent investigations on blood flow restriction (BFR) combined with resistance training in individuals with dynapenia. Read more about this study

Who is it for?
Ages 55 to 85 yearsHealthy volunteers can take part
Conditions the study is for
Dynapenia
What is being tested?
Blood Flow Restriction and Conventional Resistance Training
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
720 participants
Where
1 siteTaiwan
Study dates
Apr 2026to Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 to 85 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Aged 55 years and older.
  • No regular physical activity within the past three months, defined as exercising no more than twice per week.
  • No cognitive impairment and able to follow exercise and assessment instructions.

Who cannot join

  • Have contraindications to exercise, such as severe musculoskeletal problems, osteoporosis, deep vein thrombosis, or coagulation disorders.
  • Have comorbid conditions that are severe or end-stage, such as stroke diagnosed by a neurologist, diabetes with severe complications (e.g., retinopathy), or cardiovascular disease including heart failure, coronary ischemia, or arrhythmia.
  • Have high-risk factors for exercise, such as uncontrolled hypertension (systolic blood pressure >160 mmHg or diastolic blood pressure >100 mmHg), angina or chest tightness during exercise, or deep vein thrombosis.
  • Have a history of hematologic disorders or are currently taking blood-related medications, such as hormones or anticoagulants.
  • Are expected to move out of the local community within three months.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

LIN C Y Kaohsiung Medical University, Master contact

+8867-3121101 ext. #2646 #614

jojojeff0205@gmail.com

Taiwan1 site
  • Sports Biomechanics Laboratory

    Kaohsiung City, No. 100, Shiquan 1st Rd., Sanmin Dist., Kaohsiung City, 807

Other trials in Taiwan

About this study

Official title: The Effects of Blood Flow Restriction Training Parameters on Lower Limb Muscle Function in Elderly Adults With Dynapenia: Mechanism and Intervention Outcomes

The objective of the first year is to collect limb occlusion pressure (LOP) measurements in older adults with varying levels of muscle health, which will serve as foundational data for subsequent investigations on blood flow restriction (BFR) combined with resistance training in individuals with dynapenia. This phase aims to examine LOP values and their potential influencing factors, including demographic and physiological characteristics such as age, height, body weight, blood pressure, waist circumference, body fat percentage, medical history of chronic diseases, and habitual physical activity. Muscle-related assessments will include skeletal muscle mass, thigh and calf circumference, handgrip strength, and lower limb muscle strength. Functional performance will be evaluated using the five-times sit-to-stand test and the SARC-F questionnaire for sarcopenia risk screening. LOP of the lower limbs will be measured using a BFR cuff system combined with a laboratory-developed blood flow detection device. The study will further investigate whether LOP values are associated with the aforementioned factors.

The objective of the second year is to utilize high-density surface electromyography (dEMG) to analyze the electrophysiological characteristics of muscle contraction in individuals with sarcopenia under varying BFR pressures and resistance intensities. This includes examining motor unit recruitment patterns and recruitment thresholds, with the goal of identifying effective and appropriate BFR exercise parameters for this population.

The objective of the third year is to investigate the effects of lower limb BFR combined with resistance training on functional performance in individuals with dynapenia. Building upon the findings from the first year, this phase will implement BFR resistance training interventions and evaluate both short-term and long-term effects. Through an experimental design, the study will assess changes in body composition, muscle strength, and functional performance following a four-month intervention, along with a three-month follow-up period, to determine whether participants can improve to a healthy status and maintain these improvements over time.

Conditions
Dynapenia
Being tested
Blood Flow Restriction, Conventional Resistance Training
Keywords
Blood Flow Restriction Training, Elderly, Dynapenia, Occlusion Pressure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Blood Flow RestrictionDevice

    Leg Press Training. two sessions per week. BFR cuff set at 50-65% of Limb Occlusion Pressure, three sets of 30-15-15 repetitions in a total of 3 sets. Intensity set at 20-30% of 1RM.

    Device: Delfi Personal Tourniquet System (PTS)

  • Conventional Resistance TrainingOther

    Leg Press Training, two sessions per week, three sets per session. 8-10 repetitions each set with intensity ranging from 60%-75%.

Study groups in NCT07534150
Study groupRoleWhat they receive
Blood Flow Restriction Group (BFR)ExperimentalReceive low intensity lower limb resistance training with the use of Blood Flow Restriction
Receives: Device: Blood Flow Restriction
Conventional Resistance Training Group (CRT)Active comparatorReceive traditional high intensity lower-limb resistance training
Receives: Other: Conventional Resistance Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Baseline Data

    Collect data on participants' demographics including gender, age, education level, living situation, lifestyle habits (such as alcohol consumption and smoking), and health status with chronic disease history.

    Daily activity patterns are assessed using the International Physical Activity Questionnaire - Short Self-Administered Taiwanese Chinese Version (IPAQ), which surveys participants' activities of different intensities over the past seven days.

    Measured: week0(pre-intervention), week16(post-intervention)

  2. Muscle Strength

    Hand Grip Strength measured via a Dynamometer, recorded in kg Knee Extensor Strength measured via a hand-held Dynamometer

    Measured: week0(pre-intervention), week16(post-intervention)

  3. Muscle Function: The Short Physical Performance Battery (SPPB)

    The Short Physical Performance Battery (SPPB) evaluates lower extremity function through three tasks: standing balance (side-by-side, semi-tandem, tandem), 4-meter gait speed, and a 5-repetition chair stand test. Each task is scored from 0 (inability to complete) to 4 (best performance). The three component scores are summed for a total score ranging from 0 to 12, with higher scores indicating better physical performance.

    Unit of Measure: scores on a scale (points)

    Measured: week0(pre-intervention), week16(post-intervention)

  4. Height

    Standard Measurements: Height, recorded in centimeters.

    Measured: week0(pre-intervention), week16(post-intervention)

  5. Weight

    Standard Measurements: Weight, recorded in kilograms(kg)

    Measured: week0(pre-intervention), week16(post-intervention)

  6. BMI

    weight and height will be combined to report BMI in kg/m^2

    Measured: week0(pre-intervention), week16(post-intervention)

  7. Blood Pressure

    Measured via a Blood Pressure Monitor, Systolic Blood Pressure and Diastolic Blood Pressure will be recorded in mmHg

    Measured: week0(pre-intervention), week16(post-intervention)

  8. Circumferences

    Waist line, Thigh Circumference, Calf Circumference will be using standard tape measure and recorded in centimeter(cm)

    Measured: week0(pre-intervention), week16(post-intervention)

  9. SARC-F Questionnaire

    The questionnaire consists of five items, each scored 0, 1, or 2, with higher scores indicating greater difficulty for the participant.

    The total score ranges from 0 to 10. The items assess difficulty in Strength, Assistance in walking, Rising from a chair, Climbing, and Fall.

    A SARC-F score greater than 4 indicates a population at risk for sarcopenia.

    Measured: week0(pre-intervention)

  10. Electromyography(EMG)

    Electromyography characteristics of Vastus Lateralis and Vastus Medialis

    Measured: week0(pre-intervention), week16(post-intervention)

  11. Limb Occlusion Pressure(LOP)

    Measured in a seated position with the knee fully extended, using a laboratory-developed blood flow occlusion detection system. During the measurement, a manually inflated pressure cuff was placed at the proximal thigh near the hip joint, while a photoplethysmography (PPG) sensor and a temperature sensor were positioned over the dorsalis pedis artery on the anterior aspect of the ankle to detect distal PPG and temperature signals.

    Measured: week0(pre-intervention)

  12. Skeletal muscle mass

    Measured by Bioelectrical Impedance Analysis(BIA), recorded in kilograms(kg)

    Measured: week0(pre-intervention), week16(post-intervention)

  13. Body fat percentage

    Measured by Bioelectrical Impedance Analysis(BIA), recorded in percentage(%)

    Measured: week0(pre-intervention), week16(post-intervention)

  14. Estimated appendicular skeletal muscle mass

    Measured by Bioelectrical Impedance Analysis(BIA), recorded in kilograms(kg)

    Measured: week0(pre-intervention), week16(post-intervention)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Apr 2026
  2. Study startApr 2026 (estimated)
  3. Primary completionDec 2028 (estimated)
  4. Study completionDec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
To investigate the effects of lower limb Blood Flow Restriction(BFR) combined with resistance training on functional performance in individuals with dynapenia. Building upon the findings from the first year, this phase will implement BFR resistance training interventions and evaluate short-term and long-term effects. Through an experimental design, the study will assess changes in body composition, muscle strength, and functional performance following a four-month intervention, along with a three-month follow-up period, to determine whether participants can improve to a healthy status and maintain these improvements over time.
Masking
None (open label)
Enrolment
720 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07534150
Sponsor's protocol ID
KMUHIRB-F(I)-20250145
Status last verified
Apr 2025
First submitted
29 Mar 2026
Last updated
16 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The objective of the first year is to collect limb occlusion pressure (LOP) measurements in older adults with varying levels of muscle health, which will serve as foundational data for subsequent investigations on blood flow restriction (BFR) combined with resistance training in individuals with dynapenia. The objective of the second year is to utilize high-density surface electromyography (dEMG) to analyze the electrophysiological characteristics of muscle contraction in individuals with sarcopenia under varying BFR pressures and resistance intensities. The objective of the third year is to investigate the effects of lower limb BFR combined with resistance training on functional performance in individuals with dynapenia.

Questions about this trial

What is this clinical trial studying?

A study testing Blood Flow Restriction and Conventional Resistance Training in people with Dynapenia, run by Kaohsiung Medical University at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 16 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact LIN C Y Kaohsiung Medical University, Master (+8867-3121101 ext. #2646 #614, jojojeff0205@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Baseline Data (time frame: week0(pre-intervention), week16(post-intervention)). The study lists 14 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in